Case Report: Off Label Utilization of Topiramate and Metformin in Patients With BMI ≥50 kg/m2 Prior to Bariatric Surgery
FDA approved anti-obesity medications may not be cost effective for patients struggling with pre-operative weight loss prior to bariatric surgery. Metformin, a biguanide, and Topiramate, a carbonic anhydrase inhibitor, both cost effective medications, have demonstrated weight loss when used for the...
Main Authors: | Cetin Sari, Richard L. Seip, Devika Umashanker |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-02-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2021.588016/full |
Similar Items
-
Pharmacologic management of weight regain following bariatric surgery
by: Eugene Lucas, et al.
Published: (2023-01-01) -
Combination anti‐obesity medications to effectively treat bariatric surgery weight regain at an academic obesity center
by: Gunther Wong, et al.
Published: (2023-06-01) -
BAROS PROTOCOL IN A UNIVERSITY HOSPITAL: WHAT IS THE IMPORTANCE IN THE POSTOPERATIVE RESULTS OF BARIATRIC SURGERY?
by: João Evangelista Neto, et al.
Published: (2023-03-01) -
Semaglutide 2.4 mg clinical outcomes in patients with obesity or overweight in a real‐world setting: A 6‐month retrospective study in the United States (SCOPE)
by: Aleksandrina Ruseva, et al.
Published: (2024-02-01) -
Comparing Lifestyle and Behavior of Post-Bariatric Surgery and Participants with Obesity: A Community-Based Cross-Sectional Study
by: Althumiri NA, et al.
Published: (2024-01-01)